On November 2, 2015, Vivione Biosciences Inc. closed the transaction. The company announced that it has issued 1,000,000 series A preferred units for gross proceeds of $1,000,000.
1st Jan change | Capi. | |
---|---|---|
+14.52% | 3.05B | |
+31.41% | 2.06B | |
+8.00% | 1.51B | |
-11.54% | 1.2B | |
+14.37% | 756M | |
+9.28% | 666M | |
+33.12% | 570M | |
-4.17% | 503M | |
+25.78% | 466M |